Kong Fanming: Clinical Trials

1 trial sponsored by Kong Fanming, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Kong Fanming: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
Electroacupuncture combined with immunotherapy, Zilongjin tablet combined with immunotherapy, Immunotherapy - Non-Small Cell Lung Cancer, Electroacupuncture
Phase 2 / Phase 3RecruitingKong Fanming4052025-01-012025-06-24

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)

Interventions

Immunotherapy (1)

Countries

China (1)